Immunogen Current Assets

Immunogen (IMGN) currently reports a current assets of $740M as of September 2023. That compares with $330M in the prior-year period — up 122.8% year over year. Use the charts on this page to explore Immunogen's current assets history and peer comparisons.

Immunogen's current assets increased from $330M to $740M — a 122.8% year-over-year increase (period ending September 2023). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Immunogen reported $740M in current assets as of September 2023. That compares with $330M in the prior-year period — up 122.8% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current assets of $740M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Immunogen, and consider following IMGN for alerts when major investors trade the stock.

Immunogen is classified in the Healthcare sector. On current assets, it currently shows $740M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing IMGN with unrelated industries.